TY - JOUR
AU1 - Gui, Xi-En
AU2 - Ho, Monto
AU3 - Cohen, Myron S.
AU4 - Wang, Qi-Lan
AU5 - Huang, Hain-Ping
AU6 - Xie, Qi-Xiang
AB - Concise Communications 1047 8. Kaul TN, Welliver RC, Ogra PL. Comparison of fluorescent­ 12. McIntosh K, McQuillin J, Gardner PS. Cell-free and cell­ antibody, neutralizing-antibody, and complement­ bound antibody in nasal secretions from infants with re­ enhanced neutralizing-antibody assays for detection of se­ spiratory syncytial virus infections. Infect Immun rum antibody to respiratory syncytial virus. J Clin 1979;23:276-81 Microbiol 1981;13:957-62 13. Kaul TN, WelliverRC, Wong Dr, Udwadia RA, Riddlesberger 9. Powers CN, Peavy DL, Knight V. Selectiveinhibition of func­ K, Ogra PL. Secretory antibody response to respiratory tionallymphocyte subpopulations by ribavirin. Antimicrob syncytial virus infection. Am J Dis Child 1981;135:1013-6 Agents Chemother 1982;22:108-14 14. Hemming VG, Prince GA, Horswood RL, London WT, Mur­ 10. Connor JD, Hintz M, Van Dyke R, McCormick JB, Mcin­ phy BR, Walsh EE, Fischer GW, Weisman LE, Baron PA, tosh K. Ribavirin pharmacokinetics in children and adults Chanock RM. Studies of passive immunotherapy for in­ during therapeutic trials. In: Smith RA, Knight V, Smith fections of respiratory syncytial virus in the respiratory tract JAD, eds. Clinical applications of ribavirin. Orlando, Fla: of a primate model. J Infect Dis 1985;152:1083-7 Academic Press 1984:107-23 15. Henderson FW, Collier A, Clyde WA Jr, Denny RW. 11. McIntosh 
TI - Hemorrhagic Fever with Renal Syndrome: Treatment with Recombinant α Interferon
JF - The Journal of Infectious Diseases
DO - 10.1093/infdis/155.5.1047
DA - 1987-05-01
UR - https://www.deepdyve.com/lp/oxford-university-press/hemorrhagic-fever-with-renal-syndrome-treatment-with-recombinant-Pv4ATLcORw
SP - 1047
EP - 1051
VL - 155
IS - 5
DP - DeepDyve
ER -